Dr. Aaron Ring, MD, PhD, is an Associate Professor and Anderson Family Chair for Immunotherapy at the Fred Hutchinson Cancer Center. He completed his undergraduate studies at Yale University followed by an MD/PhD at Stanford Medical School. Dr. Ring’s research integrates protein engineering with systems immunology to discover novel targets for cancer therapy and to develop new drugs against them. Research from the Ring lab led to the development of innovative cancer immunotherapies, including drugs for the IL-18, IL-2, and SIRPα/CD47 pathways that are currently being evaluated in clinical trials. The Ring lab has also pioneered new technologies in systems immunology, including the REAP autoantibody discovery platform. In addition to his academic research, Dr. Ring founded Simcha Therapeutics, ALX Oncology, Seranova Bio, and Stipple Bio. He was named by Endpoints as “20 under 40 in Biopharma” and by Nature Biotechnology as one of the “Top 20 Translational Researchers of 2020.” He also been recognized with the Mark Foundation Emerging Leader Award, as a Pew-Stewart Scholar, an ICIS Milstein Young Investigator, and an NIH Director’s Early Independence Award recipient. Dr. Ring holds the Anderson Family Endowed Chair for Immunotherapy.

Research Interests: Taking translational research and lab operations to the next level.
Hobbies: Cooking (especially Filipino food), reading mysteries and memoirs, hiking to alpine lakes, and good coffee/wine.